Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
Add more filters











Publication year range
1.
Rev Invest Clin ; 74(4): 219-226, 2022.
Article in English | MEDLINE | ID: mdl-36087940

ABSTRACT

Background: Genetic eye disorders, affecting around one in 1000 people, encompass a diverse group of diseases causing severe visual deficiency. The recent adoption of next-generation sequencing techniques, including whole-exome sequencing (WES), in medicine has greatly enhanced diagnostic rates of genetically heterogeneous diseases. Objectives: The objectives of the study were to assess the diagnostic yield of WES in a cohort of Mexican individuals with suspected genetic eye disorders and to evaluate the improvement of diagnostic rates by reanalysis of WES data in patients without an initial molecular diagnosis. Methods: A total of 90 probands with ocular anomalies of suspected genetic origin were ascertained. Patients underwent WES in leukocytic DNA. Bioinformatics analysis and Sanger sequencing were used to confirm the disease-causing variants. Only variants identified as pathogenic or likely pathogenic were considered as causal. Results: Initial analysis revealed causal mutations in 46 cases (51%). Reanalysis of WES data 12 months after first analysis resulted in the identification of additional causal variants in 6 patients (7%), increasing the molecular diagnostic yield to 58%. The highest diagnostic rates by disease categories corresponded to hereditary retinal dystrophies (77%) and to anomalies of the anterior segment of the eye (47%). Conclusions: Our study demonstrates that WES is an effective approach for genetic diagnosis of genetic ocular diseases and that reanalysis of WES data can improve the diagnostic yield.


Subject(s)
Exome , Eye Diseases , Eye Diseases/diagnosis , Eye Diseases/genetics , High-Throughput Nucleotide Sequencing , Humans , Mutation , Exome Sequencing/methods
4.
Rev. bras. oftalmol ; 80(2): 100-106, Mar.-Apr. 2021. tab, graf
Article in English | LILACS | ID: biblio-1280105

ABSTRACT

ABSTRACT Objective: A scientometric analysis produced in ophthalmic genetics and gene therapy research is lacking. The purpose of this study is to present a holistic analysis of ophthalmic genetics literature. Methods: The data used in this study were obtained from the Web of Science (WoS) Core Collection. All published documents between 1975-2019 were included. The data exported from WoS enabled the extensive details of ophthalmic genetics related literature including countries, institutions, authors, citations and keywords. Scientometric network maps of keywords and also country and institution co-authorships were created with free software. Global contributions of the countries to the ophthalmic genetics literature were shown by a graphic. Results: The search query revealed a total of 2322 documents. Most of the documents were original articles (75.75%). USA was the leading country by producing 45.39% of all documents in ophthalmic genetics research followed by UK, Germany, China and France. Pennsylvania University was the most contributing institution in the literature (5.25%) followed by University College London and Moorfields Eye Hospital. The average citations per item was 29.4. The most used keywords over a 40-year period were 'family', 'cell', 'photoreceptor' and 'expression'. Conclusions: USA and UK dominated the ophthalmic genetics research. A substantial increase in the number of published documents in this field were observed after 2010.


RESUMO Objetivo: A literatura carece de análise cienciométrica produzida em genética oftálmica e de pesquisa em terapia genética. O objetivo deste estudo é apresentar uma análise holística da literatura genética oftálmica. Métodos: Os dados utilizados neste estudo foram obtidos na base de dados Web of Science (WoS) Core Collection. Todos os documentos publicados entre 1975 e 2019 foram incluídos na análise. Os dados exportados da WoS viabilizaram acesso a amplos detalhes da literatura relacionada à genética oftálmica, incluindo países, instituições, autores, citações e palavras-chave. Mapas de rede cienciométrica foram criados por meio de software gratuito, com base em palavras-chave e em coautorias de países e instituições. As contribuições globais dos países para a literatura sobre genética oftálmica foram apresentadas em gráfico. Resultados: a busca por pesquisas revelou um total de 2.322 documentos cuja maioria eram artigos originais (75,75%). Os EUA foram o país que mais produziu artigos sobre o tema, com 45,39% de todos os documentos em pesquisa genética oftálmica; ele foi seguido pelo Reino Unido, Alemanha, China e França. A Universidade da Pensilvânia foi a instituição que mais contribuiu para a literatura (5,25%), e foi seguida pela University College London e pelo Moorfields Eye Hospital. A média de citações por item foi de 29,4. As palavras-chave mais usadas em um período de 40 anos foram 'família', 'célula', 'fotorreceptor' e 'expressão'. Conclusões: Os EUA e o Reino Unido dominaram a pesquisa em genética oftálmica. Após 2010, observou-se um aumento substancial no número de documentos publicados nessa área.


Subject(s)
Humans , Genetic Therapy , Bibliometrics , Eye Diseases, Hereditary , Eye Diseases/genetics , Eye Diseases/therapy , Ophthalmology/trends , Periodicals as Topic/trends , Periodicals as Topic/statistics & numerical data , Publications , Publishing/statistics & numerical data , Databases, Factual , Genomics/trends , Genetic Research
5.
Benef Microbes ; 12(2): 163-174, 2021 Apr 12.
Article in English | MEDLINE | ID: mdl-33769229

ABSTRACT

Anti-inflammatory effect of soluble secreted compounds of probiotic bacteria was widely demonstrated as therapy for different inflammatory diseases, but was not investigated in inflammatory eye disorders. The aim of this study was to determine whether Lactiplantibacillus plantarum CRL759 cell-free supernatant reduced inflammatory parameters and clinical signs in ocular inflammations. First, we evaluated the effect of L. plantarum CRL759 supernatant in vitro on human retinal cell line, ARPE-19 cells, stimulated with lipopolysaccharide (LPS). Then, we investigated in vivo its capacity to decrease inflammation by local administration on the eyes of mice with endotoxin induced inflammation. In vitro assays demonstrated that L. plantarum CRL759 supernatant reduced the production of interleukin (IL)-6, IL-8, nitric oxide and thiobarbituric acid reactive substances in LPS-stimulated ARPE-19 cells. Our in vivo data proved that L. plantarum supernatant significantly reduced the clinical score of endotoxin treated mice and diminished levels of tumour necrosis factor alpha, interferon gamma and protein concentration in aqueous humour. Histological examination showed reduction of infiltrating inflammatory cells in the posterior segment of the eyes. As far as we know, this is the first report showing that Lactobacillus spp. supernatant administered as drops reduces some parameters of ocular inflammation. This promising strategy is safe and could alleviate symptoms and signs of ocular inflammation in people that are refractories to the conventional therapies.


Subject(s)
Eye Diseases/drug therapy , Eye Diseases/immunology , Probiotics/administration & dosage , Animals , Disease Models, Animal , Drug Evaluation, Preclinical , Eye Diseases/etiology , Eye Diseases/genetics , Female , Humans , Interleukin-6/genetics , Interleukin-6/immunology , Interleukin-8/genetics , Interleukin-8/immunology , Lactobacillus plantarum/physiology , Lipopolysaccharides/adverse effects , Male , Mice , Mice, Inbred C57BL , Ophthalmic Solutions/administration & dosage , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
6.
Anim Genet ; 51(6): 935-939, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33058316

ABSTRACT

The study of skin color in cattle holds both economic and scientific interest. Several ocular diseases of cattle have been associated with low pigmentation of the eyelids, including ocular squamous cell carcinoma and infectious keratoconjunctivitis, the two most common ocular diseases affecting cattle production. Although low eyelid pigmentation is a well-known risk factor for various ocular diseases, the genetic and biological basis of this relationship is largely unknown. We investigated the transcriptome of eyelid skin in Hereford cattle using RNA-sequencing technology. Two contrasting groups were evaluated: steers that were completely pigmented and steers with no pigmentation in both eyelids. Most of the up-regulated genes in pigmented samples are directly implicated in melanogenesis and melanosome development, whereas up-regulated genes in non-pigmented samples are implicated in cancer development and the immune system, among other functions. Interestingly, network analysis comparing pigmented vs. non-pigmented samples revealed significant differences in the co-expression patterns of genes related to melanosome, pigmentation and defense response to bacteria, showing higher gene activity, greater co-expression patterns and tighter co-regulation mechanisms in pigmented samples. Overall, our findings indicate that bovine eyelid pigmentation depends on the expression of many genes involved not only in pigmentation and melanosome function but also related to inflammatory response, infection and tumoral pathways.


Subject(s)
Cattle/genetics , Eyelids , Pigmentation/genetics , Transcriptome , Animals , Breeding , Eye Diseases/genetics , Eye Diseases/veterinary , Gene Expression , Male , Melanins/biosynthesis , Melanosomes/genetics , Phenotype
7.
J Neurol Sci ; 409: 116620, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31865189

ABSTRACT

Ophthalmological abnormalities may occur in specific subtypes of hereditary spastic paraplegia (HSP) and in genetic diseases that present with spastic paraplegia mimicking HSP. These ophthalmological changes may precede the motor symptoms and include pigmentary retinal degeneration, ophthalmoplegia, optic atrophy, cataracts and nystagmus. Some ophthalmological abnormalities are more prevalent in specific forms of HSP. Considering that the diagnosis of HSP is usually difficult and complex, specific ophthalmological changes may guide the genetic testing. There are other genetic diseases such as autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), X-linked adrenoleukodystrophy and spastic paraplegia, optic atrophy and neuropathy (SPOAN) that may mimic HSP and also may present with specific ophthalmological changes. In this article, we review the main ophthalmological changes observed in patients with HSP and HSP-like disorders.


Subject(s)
Diagnostic Techniques, Ophthalmological , Eye Diseases/diagnostic imaging , Eye Diseases/genetics , Spastic Paraplegia, Hereditary/diagnostic imaging , Spastic Paraplegia, Hereditary/genetics , Eye Diseases/epidemiology , Humans , Muscle Spasticity/diagnostic imaging , Muscle Spasticity/epidemiology , Muscle Spasticity/genetics , Optic Atrophy/diagnostic imaging , Optic Atrophy/epidemiology , Optic Atrophy/genetics , Paraplegia/diagnostic imaging , Paraplegia/epidemiology , Paraplegia/genetics , Spastic Paraplegia, Hereditary/epidemiology , Spinocerebellar Ataxias/congenital , Spinocerebellar Ataxias/diagnostic imaging , Spinocerebellar Ataxias/epidemiology , Spinocerebellar Ataxias/genetics
8.
Am J Case Rep ; 20: 1566-1571, 2019 Oct 25.
Article in English | MEDLINE | ID: mdl-31649234

ABSTRACT

BACKGROUND Encephalocraniocutaneous lipomatosis is a rare neurocutaneous disorder characterized by cutaneous, ocular, and central nervous system anomalies; its molecular etiology was recently identified. This report describes the surgical treatment and genetic characterization of a giant ocular lipodermoid cyst secondary to encephalocraniocutaneous lipomatosis. CASE REPORT An 11-year-old girl with past medical history of absence seizures presented with a reddish protruding mass in her right eye involving the temporal conjunctiva and the peripheral temporal cornea; eyelid closure was not possible due to mass protrusion. She also presented skin tags at the level of the external canthus and 3 alopecic areas at the level of the scalp compatible with nevus psiloliparus. No family history was reported. A dermoid cyst was suspected and excisional biopsy was performed under general anesthesia. A large conjunctival and lamellar corneoscleral resection was done, followed by a corneal tectonic graft. Molecular analysis was carried out, including PCR and Sanger sequencing on DNA obtained from the mass. After surgery, the patient achieved complete eyelid closure, reduction of ocular surface symptoms, and improved aesthetic appearance. Histological analysis confirmed a lipodermoid cyst; genetic tests confirmed a mosaic activating mutation in FGFR1 (c.1638C>A, p.Asn546Lys). The diagnosis was encephalocraniocutaneous lipomatosis. CONCLUSIONS ECCL is a rare condition; an accurate diagnosis comprising clinical and genetic aspects can facilitate the monitoring of possible complications, improve the multidisciplinary treatment, and provide valuable information for future therapy developments. In this case, the patient's quality of life improved significantly, ocular symptoms disappeared, and a good esthetic appearance was achieved.


Subject(s)
Dermoid Cyst/genetics , Dermoid Cyst/surgery , Eye Diseases/diagnosis , Eye Diseases/genetics , Eye Neoplasms/genetics , Eye Neoplasms/surgery , Lipomatosis/diagnosis , Lipomatosis/genetics , Neurocutaneous Syndromes/diagnosis , Neurocutaneous Syndromes/genetics , Receptor, Fibroblast Growth Factor, Type 1/genetics , Biopsy , Child , Corneal Transplantation , DNA Mutational Analysis , Dermoid Cyst/etiology , Eye Diseases/complications , Eye Neoplasms/etiology , Female , Humans , Lipomatosis/complications , Neurocutaneous Syndromes/complications , Polymerase Chain Reaction , Seizures/etiology
9.
Mol Genet Genomic Med ; 7(5): e625, 2019 05.
Article in English | MEDLINE | ID: mdl-30891959

ABSTRACT

BACKGROUND: Postzygotic KRAS, HRAS, NRAS, and FGFR1 mutations result in a group of mosaic RASopathies characterized by related developmental anomalies in eye, skin, heart, and brain. These oculocutaneous disorders include oculoectodermal syndrome (OES) encephalo-cranio-cutaneous lipomatosis (ECCL), and Schimmelpenning-Feuerstein-Mims syndrome (SFMS). Here, we report the results of the clinical and molecular characterization of a novel cohort of patients with oculocutaneous mosaic RASopathies. METHODS: Two OES, two ECCL, and two SFMS patients were ascertained in the study. In addition, two subjects with unilateral isolated epibulbar dermoids were also enrolled. Molecular analysis included PCR amplification and Sanger sequencing of KRAS, HRAS, NRAS, and FGFR1 genes in DNA obtained from biopsies (skin/epibulbar dermoids), buccal mucosa, and blood leukocytes. Massive parallel sequencing was employed in two cases with low-level mosaicism. RESULTS: In DNA from biopsies, mosaicism for pathogenic variants, including KRAS p.Ala146Thr in two OES subjects, FGFR1 p.Asn546Lys and KRAS p.Ala146Val in ECCL patients, and KRAS p.Gly12Asp in both SFMS patients, was demonstrated. No mutations were shown in DNA from conjunctival lesions in two subjects with isolated epibubar dermoids. CONCLUSION: Our study allowed the expansion of the clinical spectrum of mosaic RASopathies and supports that mosaicism for recurrent mutations in KRAS and FGFR1 is a commonly involved mechanism in these rare oculocutaneous anomalies.


Subject(s)
Dermoid Cyst/genetics , Ectodermal Dysplasia/genetics , Eye Diseases/genetics , Lipomatosis/genetics , Neurocutaneous Syndromes/genetics , Nevus, Sebaceous of Jadassohn/genetics , Phenotype , Receptor, Fibroblast Growth Factor, Type 1/genetics , Dermoid Cyst/pathology , Ectodermal Dysplasia/pathology , Eye Diseases/pathology , GTP Phosphohydrolases/genetics , Humans , Lipomatosis/pathology , Membrane Proteins/genetics , Mosaicism , Neurocutaneous Syndromes/pathology , Nevus, Sebaceous of Jadassohn/pathology , Proto-Oncogene Proteins p21(ras)/genetics
10.
J Mol Neurosci ; 67(3): 441-444, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30607898

ABSTRACT

Primary familial brain calcification (PFBC) is a rare neurodegenerative disorder characterized by symmetrical and bilateral brain calcification. It is typically inherited as an autosomal dominant disorder, and de novo variants have also been described. Interestingly, just recent studies have reported the first autosomal recessive PFBC-causative gene. PFBC patients exhibit high clinical heterogeneity including Parkinsonism, dystonia, ataxia, depression, and migraine. Mice studies, an important research tool, have been a breakthrough in increasing the understanding of PFBC's main signs and symptoms, and many findings reported in these mice have been subsequently reported in patients. One phenotype that has been observed in PFBC mice models but not in PFBC patients, however, is the development of ophthalmic abnormalities. This way, this report focused on performing an ophthalmic assessment in six Brazilian patients genetically diagnosed with PFBC. The assessments showed that none of the PFBC individuals included presented any of the ophthalmic abnormalities reported in mice models, such as cataracts, ocular calcification, abnormal iris and lens morphology, and retinal deterioration. Additionally, of the six PFBC patients described, two SLC20A2 mutation carriers showed physiological excavation of the optic nerve head and partial vitreous detachment, while just one individual presented bilateral narrowing of retinal arterioles. In summary, no evidence of similar ophthalmological abnormalities found in mice were found in our patients; nonetheless, further studies in larger sample size are warranted to corroborate with our findings. To our knowledge, this study is the first to focus on investigating, in PFBC patients, the ophthalmological phenotypes described in the PFBC mice models.


Subject(s)
Brain/metabolism , Calcinosis/genetics , Eye Diseases/genetics , Proto-Oncogene Proteins c-sis/genetics , Sodium-Phosphate Cotransporter Proteins, Type III/genetics , Animals , Brain/pathology , Calcinosis/pathology , Eye Diseases/pathology , Humans , Mice
12.
In. Santiesteban Freixas, Rosaralis. Oftalmología pediátrica. 2da ed. La Habana, Editorial Ciencias Médicas, 2 ed; 2018. , ilus.
Monography in Spanish | CUMED | ID: cum-70929
13.
Eye (Lond) ; 32(1): 120-127, 2018 01.
Article in English | MEDLINE | ID: mdl-28799562

ABSTRACT

PurposeTo analyze the relation between ophthalmologic and motor changes in spinocerebellar ataxia type 7 (SCA7).Patients and methodsThis was a case series study. Sixteen SCA7 patients underwent a comprehensive ophthalmic examination, including ocular extrinsic motility testing, color vision test, and optical coherence tomography of the optic nerve and macula. Changes in the corneal endothelium, electroretinographic patterns, and a complete neurologic evaluation using the Scale for the Assessment and Rating of Ataxia (SARA) were evaluated. Correlations of endothelial cell density (ECD) with number of CAG repetitions and the SARA scores were estimated.ResultsAll patients showed various degrees of visual impairment mainly due to macular deterioration. Notably, they also presented decreased ECD. Pairwise correlations of ECD with number of CAG repeats and severity of motor symptoms quantified with the SARA scores were inverse (r=-0.46, P=0.083 and r=-0.64, P=0.009, respectively). Further analyses indicated an average ECD decrease of 48 cells/mm2 (P=0.006) per unit of change on the number of CAG repeats, and of 75 cells/mm2 (P=0.001) per unit of change on the SARA scores.ConclusionsThe results agree with previous ophthalmological findings regarding the widespread effect of SCA7 mutation on the patient's visual system. However, the results also show a significant negative correlation of decreased ECD with both CAG repetitions and SARA scores. This suggests that motor systems could degenerate in parallel with visual systems, although more research is needed to determine whether the degeneration is caused by the same mechanisms.


Subject(s)
Anterior Eye Segment/diagnostic imaging , Color Vision , Eye Diseases/diagnosis , Spinocerebellar Ataxias/complications , Visual Acuity , Adult , Aged , Corneal Topography , Electroretinography , Eye Diseases/etiology , Eye Diseases/genetics , Female , Humans , Male , Middle Aged , Severity of Illness Index , Spinocerebellar Ataxias/diagnosis , Spinocerebellar Ataxias/genetics , Tomography, Optical Coherence , Young Adult
14.
Gene ; 614: 26-36, 2017 May 30.
Article in English | MEDLINE | ID: mdl-28257834

ABSTRACT

The eye is immunologically privileged when inflammatory responses are suppressed. One component responsible for the suppression of inflammatory responses is the blood retinal barrier, which comprises the retinal pigment epithelium. The destruction of this barrier initiates inflammation, which can affect any part of the eye. Therefore, inflammatory response is controlled by the action of anti-inflammatory mediators, among these mediators, annexin A1 (ANXA1) protein acts as a modulator of inflammation. In this study we aimed to improve the knowledge of this area by investigating how a peptide of the ANXA1 protein (ANXA1Ac2-26) modulates the morphology, proliferation, migration and expression of genes and proteins in human retinal pigment epithelium cells (ARPE-19). Determining how signaling pathways (NF-κB and UBC) are modulated by the ANXA1Ac2-26 peptide could be important for understanding the inflammatory process. ARPE-19 cells were activated by bacterial lipopolysaccharide endotoxin (LPS) and treated with ANXA1Ac2-26 peptide, in a concentration of 1.7µM and 33.8µM. We observed that the LPS activation diminished the levels of endogenous ANXA1 after 2h and 24h and ANXA1Ac2-26 peptide decreased the proliferation and re-establishes the migration of ARPE-19 cells. After using a hybridization approach, 80 differentially expressed genes were found. Five of these genes were selected (LRAT, CTGF, MAP1B, ALDH1A3 and SETD7) and all were down-regulated after treatment with the peptide. The genes CTGF and LRAT would be considered as potential molecular markers of ophthalmologic inflammation. The expression of pro-inflammatory cytokines was also decreased after the treatment, indicating the efficiency of the anti-inflammatory peptide at high concentrations, since the reduction in the levels of these mediators were observed after the treatment with ANXA1Ac2-26 peptide at 33.8µM. Our results suggest that the retinal pigment epithelial cells are a potential target of the ANXA1 protein and point to possible applications of the ANXA1Ac2-26 peptide as an innovative therapy for the treatment of ocular inflammation.


Subject(s)
Annexin A1/pharmacology , Cell Movement/drug effects , Cell Proliferation/drug effects , Peptides/pharmacology , Retinal Pigment Epithelium/drug effects , Acyltransferases/genetics , Acyltransferases/metabolism , Annexin A1/chemistry , Annexin A1/metabolism , Anti-Inflammatory Agents/pharmacology , Blotting, Western , Cell Line , Cell Movement/genetics , Cell Proliferation/genetics , Connective Tissue Growth Factor/genetics , Connective Tissue Growth Factor/metabolism , Cytokines/genetics , Cytokines/metabolism , Down-Regulation/drug effects , Enzyme-Linked Immunosorbent Assay , Eye Diseases/genetics , Eye Diseases/prevention & control , Gene Expression/drug effects , Gene Expression Profiling/methods , Gene Regulatory Networks/drug effects , Humans , Inflammation/genetics , Inflammation/prevention & control , Lipopolysaccharides/pharmacology , Peptides/chemistry , Peptides/metabolism , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/metabolism , Reverse Transcriptase Polymerase Chain Reaction
15.
Gac Med Mex ; 151(4): 501-11, 2015.
Article in Spanish | MEDLINE | ID: mdl-26290027

ABSTRACT

Gene therapy is a promising new therapeutic strategy that could provide a novel and more effective way of targeting hereditary ophthalmological diseases. The eye is easily accessible, highly compartmentalized, and an immune-privileged organ that gives advantages as an ideal gene therapy target. Recently, important advances in the availability of various intraocular vector delivery routes and viral vectors that are able to efficiently transduce specific ocular cell types have been described. Gene therapy has advanced in some retinal inherited dystrophies; in this way, preliminary success is now being reported for the treatment of Leber congenital amaurosis (LCA). This review will provide an update in the field of gene therapy for the treatment of ocular inherited diseases.


Subject(s)
Eye Diseases/genetics , Eye Diseases/therapy , Genetic Therapy , Forecasting , Genetic Therapy/methods , Humans
16.
Ophthalmic Genet ; 36(3): 234-8, 2015.
Article in English | MEDLINE | ID: mdl-24417560

ABSTRACT

OBJECTIVES: Williams-Beuren Syndrome (WBS) is a multisystem disorder caused by the deletion of contiguous genes on chromosome 7q11.23. Ophthalmologic abnormalities and deficits in visual motor integration are important features of WBS. Here we describe our experience with Brazilian WBS patients and their ophthalmologic features. METHODS: Sixteen patients with confirmed WBS went through thorough ophthalmologic examination. RESULTS: The most frequent ocular findings in our group of patients were stellate iris pattern (81.2%), hyperopic astigmatism (50%), hyperopia (37.5%), tortuosity of retinal vessel (37.5%) and strabismus (18.7%). CONCLUSIONS: This is the second report of ophthalmologic abnormalities in a group of Brazilian individuals with WBS. It is extremely valuable that specific populations are studied so that clinical diagnosis can be refined and management of patients can be driven to the most common presentations of the disease.


Subject(s)
Eye Diseases/diagnosis , Williams Syndrome/diagnosis , Adolescent , Adult , Astigmatism/diagnosis , Brazil/epidemiology , Child , Child, Preschool , Elastin/genetics , Eye Diseases/epidemiology , Eye Diseases/genetics , Female , Humans , Hyperopia/diagnosis , In Situ Hybridization, Fluorescence , Iris Diseases/diagnosis , Lim Kinases/genetics , Loss of Heterozygosity , Male , Microsatellite Repeats , Polymerase Chain Reaction , Real-Time Polymerase Chain Reaction , Retinal Vessels/pathology , Strabismus/diagnosis , Williams Syndrome/epidemiology , Williams Syndrome/genetics
17.
Vet Ophthalmol ; 18(5): 385-92, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25338739

ABSTRACT

OBJECTIVES: The aim of this study was to compare ocular dimensions, corneal curvature, and corneal thickness between horses affected with hereditary equine regional dermal asthenia (HERDA) and unaffected horses. ANIMALS: Five HERDA-affected quarter horses and five healthy control quarter horses were used. METHODS: Schirmer's tear test, tonometry, and corneal diameter measurements were performed in both eyes of all horses prior to ophthalmologic examinations. Ultrasonic pachymetry was performed to measure the central, temporal, nasal, dorsal, and ventral corneal thicknesses in all horses. B-mode ultrasound scanning was performed on both eyes of each horse to determine the dimensions of the ocular structures and to calculate the corneal curvature. RESULTS: Each corneal region examined in this study was thinner in the affected group compared with the healthy control group. However, significant differences in corneal thickness were only observed for the central and dorsal regions. HERDA-affected horses exhibited significant increases in corneal curvature and corneal diameter compared with unaffected animals. The ophthalmologic examinations revealed mild corneal opacity in one eye of one affected horse and in both eyes of three affected horses. No significant between-group differences were observed for Schirmer's tear test, intraocular pressure, or ocular dimensions. CONCLUSIONS: Hereditary equine regional dermal asthenia-affected horses exhibit decreased corneal thickness in several regions of the cornea, increased corneal curvature, increased corneal diameter, and mild corneal opacity. Additional research is required to determine whether the increased corneal curvature significantly impacts the visual accuracy of horses with HERDA.


Subject(s)
Asthenia/veterinary , Cornea/pathology , Eye Diseases/veterinary , Eye/pathology , Horse Diseases/pathology , Animals , Asthenia/genetics , Asthenia/pathology , Case-Control Studies , Cornea/anatomy & histology , Corneal Pachymetry/veterinary , Eye/anatomy & histology , Eye/diagnostic imaging , Eye Diseases/diagnostic imaging , Eye Diseases/genetics , Eye Diseases/pathology , Female , Horse Diseases/diagnostic imaging , Horse Diseases/genetics , Horses/anatomy & histology , Male , Tonometry, Ocular/veterinary , Ultrasonography
18.
Clin Exp Ophthalmol ; 38(4): 367-74, 2010 May.
Article in English | MEDLINE | ID: mdl-20491809

ABSTRACT

PURPOSE: To present the results of molecular analysis of the NDP gene in Mexican families with Norrie disease (ND) and X-linked familial exudative vitreoretinopathy (XL-FEVR). METHODS: Two unrelated families with ND and two with XL-FEVR were studied. Clinical diagnosis was suspected on the basis of a complete ophthalmologic examination. Molecular methods included DNA isolation from peripheral blood leucocytes, polymerase chain reaction amplification and direct nucleotide sequencing analysis of the complete coding region and exon-intron junctions of NDP. Haplotype analysis using NDP-linked microsatellites markers was performed in both ND families. RESULTS: A novel Norrin missense mutation, p.Arg41Thr, was identified in two apparently unrelated families with ND. Haplotype analysis demonstrated that affected males in these two families shared the same ND-linked haplotype, suggesting a common origin for this novel mutation. The previously reported p.Arg121Trp and p.Arg121Gln Norrin mutations were identified in the two families with XL-FEVR. CONCLUSION: Our results expand the mutational spectrum in ND. This is the first report of ND resulting from mutation at arginine position 41 of Norrin. Interestingly, mutations at the same residue but resulting in a different missense change were previously described in subjects with XL-FEVR (p.Arg41Lys) or persistent fetal vasculature syndrome (p.Arg41Ser), indicating that the novel p.Arg41Thr change causes a more severe retinal phenotype. Preliminary data suggest a founder effect for the ND p.Arg41Thr mutation in these two Mexican families.


Subject(s)
Exudates and Transudates/metabolism , Eye Diseases/genetics , Eye Proteins/genetics , Genes, X-Linked , Mutation, Missense , Nerve Tissue Proteins/genetics , Rare Diseases/genetics , Retinal Diseases/genetics , Vitreous Body , Adult , Arginine , Base Sequence , Child, Preschool , Eye Diseases/metabolism , Haplotypes , Humans , Infant, Newborn , Male , Pedigree , Rare Diseases/diagnostic imaging , Rare Diseases/pathology , Recurrence , Retinal Diseases/diagnostic imaging , Retinal Diseases/metabolism , Retinal Diseases/pathology , Threonine , Ultrasonography , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL